Biomm S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was BRL 104.95 million compared to BRL 107.09 million a year ago. Net loss was BRL 92.56 million compared to BRL 80.26 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.96 BRL | +1.08% | -11.33% | +176.12% |
18/04 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
17/04 | Biocon Limited Signs an Exclusive Licensing and Supply Agreement with Biomm S.A | CI |
1st Jan change | Capi. | |
---|---|---|
+176.12% | 28Cr | |
+8.29% | 11TCr | |
+10.21% | 10TCr | |
-11.90% | 2.24TCr | |
+0.35% | 2.23TCr | |
-5.48% | 1.91TCr | |
-37.36% | 1.8TCr | |
-5.17% | 1.79TCr | |
+7.70% | 1.43TCr | |
+37.65% | 1.25TCr |
- Stock Market
- Equities
- BIOM3 Stock
- News Biomm S.A.
- Biomm S.A. Reports Earnings Results for the Full Year Ended December 31, 2022